Study in Low Risk Gastrointestinal Stromal Tumor (GISTs)

CompletedOBSERVATIONAL
Enrollment

700

Participants

Timeline

Start Date

November 25, 2020

Primary Completion Date

December 30, 2021

Study Completion Date

December 20, 2023

Conditions
GIST
Interventions
OTHER

Treatment of Low Risk GISTs according clinical practice (includes drugs, surgery or any other received treatments)

This observational study collects all the treatments received by the patients according clinical practices or experimental trials and therefore includes drug/biological/surgical and any other applicable treatments

Trial Locations (13)

10060

Fondazione del Piemonte per l'Oncologia IRCC Candiolo, Candiolo

20089

Istituto Clinico Humanitas, Rozzano

20133

Fondazione IRCCS INT Milano, Milan

20141

Istituto Europeo di Oncologia, Milan

33081

Centro di Riferimento Oncologico - Unit of Medical Oncology, Aviano

40138

Policlinico S.Orsola Malpighi - Unit of Medical Oncology, Bologna

40139

Azienda Ospedaliero-Universitaria Di Bologna, Bologna

50100

Azienda Ospedaliera Universitaria Careggi, Florence

59100

Nuovo Ospedale di Prato, Prato

90127

Azienda Ospedaliera Universitaria Paolo Giaccone, Palermo

00128

Policlinico Universitario Campus Biomedico, Roma

Unknown

Ospedale San Giovanni Bosco, Torino

00144

Istituto Nazionale Tumori Regina Elena - Unit of Medical Oncology I, Roma

All Listed Sponsors
lead

Italian Sarcoma Group

NETWORK

NCT04599660 - Study in Low Risk Gastrointestinal Stromal Tumor (GISTs) | Biotech Hunter | Biotech Hunter